Gene · 3376
Papers2,904
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 2,904
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Polymyositis Presenting With Nontraumatic Rhabdomyolysis and Dysphagia: A Case Report. | J Investig Med High Impact Case Rep | 2022 | 35264047 | PubTator, text mining | PubMed |
| FX5, a non-steroidal glucocorticoid receptor antagonist, ameliorates diabetic cognitive impairment in mice. | Acta Pharmacol Sin | 2022 | 35260821 | PubTator, text mining | PubMed |
| Histone deacetylase inhibitors inhibit cervical cancer growth through Parkin acetylation-mediated mitophagy. | Acta Pharm Sin B | 2022 | 35256949 | PubTator, text mining | PubMed |
| Transcriptomic Analysis of Papillary Thyroid Cancer: A Focus on Immune-Subtyping, Oncogenic Fusion, and Recurrence. | Clin Exp Otorhinolaryngol | 2022 | 35255661 | PubTator, text mining | PubMed |
| A Bioinformatics Approach Toward Unravelling the Synaptic Molecular Crosstalk Between Alzheimer's Disease and Diabetes. | J Alzheimers Dis | 2022 | 35253743 | PubTator, text mining | PubMed |
| B1 repetitive sequence methylation enhances wound healing of second-degree burns in rats. | Biomed Rep | 2022 | 35251607 | PubTator, text mining | PubMed |
| Functional Domains of the Early Proteins and Experimental and Epidemiological Studies Suggest a Role for the Novel Human Polyomaviruses in Cancer. | Front Microbiol | 2022 | 35250950 | PubTator, text mining | PubMed |
| Epiplakin1 promotes the progression of esophageal squamous cell carcinoma by activating the PI3K-AKT signaling pathway. | Thorac Cancer | 2022 | 35238170 | PubTator, text mining | PubMed |
| A master autoantigen-ome links alternative splicing, female predilection, and COVID-19 to autoimmune diseases. | J Transl Autoimmun | 2022 | 35237749 | PubTator, text mining | PubMed |
| Endoplasmic Reticulum Stress Is Involved in Muscular Pathogenesis in Idiopathic Inflammatory Myopathies. | Front Cell Dev Biol | 2022 | 35237595 | PubTator, text mining | PubMed |
| Mutation-specific reporter for optimization and enrichment of prime editing. | Nat Commun | 2022 | 35232966 | PubTator, text mining | PubMed |
| Evidence that the transcriptional repressor ICER is regulated via the N-end rule for ubiquitination. | Exp Cell Res | 2022 | 35227662 | PubTator, text mining | PubMed |
| GLTSCR1 coordinates alternative splicing and transcription elongation of ZO1 to regulate colorectal cancer progression. | J Mol Cell Biol | 2022 | 35218185 | PubTator, text mining | PubMed |
| Metformin: Expanding the Scope of Application-Starting Earlier than Yesterday, Canceling Later. | Int J Mol Sci | 2022 | 35216477 | PubTator, text mining | PubMed |
| Metformin's Mechanism of Action Is Stimulation of the Biosynthesis of the Natural Cyclic AMP Antagonist Prostaglandylinositol Cyclic Phosphate (Cyclic PIP). | Int J Mol Sci | 2022 | 35216316 | PubTator, text mining | PubMed |
| Effects of the Operating Ambiance and Active Layer Treatments on the Performance of Magnesium Fluoride Based Bipolar RRAM. | Nanomaterials (Basel) | 2022 | 35214934 | PubTator, text mining | PubMed |
| "Superwobbling" and tRNA-34 Wobble and tRNA-37 Anticodon Loop Modifications in Evolution and Devolution of the Genetic Code. | Life (Basel) | 2022 | 35207539 | PubTator, text mining | PubMed |
| The Role of Selenoprotein Tissue Homeostasis in MetS Programming: Energy Balance and Cardiometabolic Implications. | Antioxidants (Basel) | 2022 | 35204276 | PubTator, text mining | PubMed |
| Dysregulation of β-Cell Proliferation in Diabetes: Possibilities of Combination Therapy in the Development of a Comprehensive Treatment. | Biomedicines | 2022 | 35203680 | PubTator, text mining | PubMed |
| Shared Molecular Mechanisms among Alzheimer's Disease, Neurovascular Unit Dysfunction and Vascular Risk Factors: A Narrative Review. | Biomedicines | 2022 | 35203654 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3376/papers?page=39